RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy
SEATTLE, April 16, 2018 /PRNewswire/ — RareCyte, Inc., a global rare cell detection and liquid biopsy company, announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest member of the CyteFinder family, enables high-speed whole slide imaging with up to six channels... Read more